(Q24630470)

21 June 2017

title

Activity enhances dopaminergic long-duration response in Parkinson disease (English)

1 reference

21 June 2017

1 reference

1 reference

Un Jung Kang

1

1 reference

21 June 2017

Peggy Auinger

series ordinal

2

1 reference

21 June 2017

Parkinson Study Group ELLDOPA Investigators

series ordinal

3

1 reference

21 June 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

21 June 2017

1 reference

21 June 2017

volume

78

1 reference

21 June 2017

issue

15

1 reference

21 June 2017

page(s)

1146-1149

1 reference

Dopamine-dependent motor learning: insight into levodopa's long-duration response.

21 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Dichotomous dopaminergic control of striatal synaptic plasticity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Levodopa and the progression of Parkinson's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Evolution of the response to levodopa during the first 4 years of therapy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466780

Short‐ and long‐duration responses to levodopa during the first year of levodopa therapy

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22459675

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacodynamics of the long-duration response to levodopa in PD.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22459675

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E31824F8056

1 reference

OpenCitations bibliographic resource ID

21 June 2017

4880937

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4880937

1 reference